You are here:

budesonide (Budenofalk)

Advice

Following a full submission:

budesonide gastro-resistant capsule (Budenofalk®) is accepted for use within NHS Scotland.

Indication under review: symptomatic relief of chronic diarrhoea due to collagenous colitis.

budesonide (Budenofalk®) provides symptomatic improvement of diarrhoea associated with collagenous colitis compared with placebo.

Drug Details

Drug Name: budesonide (Budenofalk)
SMC Drug ID: 828/12
Manufacturer: Dr Falk Pharma UK
Indication: For the symptomatic relief of chronic diarrhoea due to collagenous colitis.
BNF Category:
Sub Category: 1.5 Chronic bowel disorders
Submission Type: Full submission
Status: Accepted
Date Advice Published: 14 January 2013

Back